Literature DB >> 16690882

Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling.

Ryota Uemura1, Meifeng Xu, Nauman Ahmad, Muhammad Ashraf.   

Abstract

In this study, we hypothesized that bone marrow stem cells (BMSCs) protect ischemic myocardium through paracrine effects that can be further augmented with preconditioning. In in vitro experiments, cell survival factors such as Akt and eNOS were significantly increased in BMSCs following anoxia. In the second series of experiments following coronary ligation in mice, left ventricles were randomly injected with the following: DMEM (G-1), BMSCs (G-2), and preconditioned BMSCs (G-3). Four days after myocardial infarction, BMSCs were observed within injured myocardium in G-2 and G-3. Apoptotic cardiomyocytes within periinfarct area were significantly reduced in G-3. Four weeks after myocardial infarction, smaller left ventricular (LV) dimension and increased LV ejection fraction were observed in G-3. Infarct area was significantly reduced in G-3. However, GFP+ cardiomyocytes were observed in low numbers within periinfarct area in G-2 and G-3. In conclusion, BMSCs secreted cell survival factors under ischemia, and they prevented apoptosis in cardiomyocytes adjacent to the infarcted area. Preconditioning of BMSCs enhanced their survival and ability to attenuate LV remodeling, which was attributable, in part, to paracrine effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690882     DOI: 10.1161/01.RES.0000225952.61196.39

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  235 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 2.  Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.

Authors:  Sangho Lee; Young-Sup Yoon
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 3.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

Review 4.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 5.  Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche.

Authors:  Gemma M Balmer; Paul R Riley
Journal:  J Cardiovasc Transl Res       Date:  2012-06-15       Impact factor: 4.132

Review 6.  De novo myocardial regeneration: advances and pitfalls.

Authors:  Khawaja Husnain Haider; Stephanie Buccini; Rafeeq P H Ahmed; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2010-10-12       Impact factor: 8.401

Review 7.  The paracrine effect: pivotal mechanism in cell-based cardiac repair.

Authors:  Simon Maltais; Jacques P Tremblay; Louis P Perrault; Hung Q Ly
Journal:  J Cardiovasc Transl Res       Date:  2010-06-08       Impact factor: 4.132

Review 8.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

9.  Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.

Authors:  Prasanna Krishnamurthy; Melissa Thal; Suresh Verma; Eneda Hoxha; Erin Lambers; Veronica Ramirez; Gangjian Qin; Douglas Losordo; Raj Kishore
Journal:  Circ Res       Date:  2011-09-29       Impact factor: 17.367

10.  IL-15: a novel prosurvival signaling pathway in cardiomyocytes.

Authors:  Yerem Yeghiazarians; Norman Honbo; Isabella Imhof; Brandon Woods; Vanessa Aguilera; Jianqin Ye; Andrew J Boyle; Joel S Karliner
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.